Aventis Apidra Clears FDA; Rapid-Acting Insulin Launch Awaits Delivery Device Approval

Aventis will wait until the OptiClick delivery device is approved before launching Apidra; the company filed for approval of the device in February. The rapid-acting insulin is approved by FDA April 16.